article thumbnail

Novaliq’s dry eye disease therapy receives US FDA approval

Pharmaceutical Technology

It has been designed to address the unmet needs of patients and to provide quick action and well-tolerated dry eye drug therapy. Novaliq medical science and regulatory affairs vice-president Sonja Krösser stated: “We are proud that the FDA approved VEVYE.

article thumbnail

Why R&D innovation holds the key to greater patient impact

European Pharmaceutical Review

3 With greater scientific understanding of cancer, the industry has made significant progress in developing innovative medicines to help patients. However, access to these medicines is not close to meeting patient demand, creating inequalities in the health prospects of those diagnosed with cancer. 1,2 In the EU, an estimated 2.7

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Dapagliflozin approved for heart failure across LVEFs

European Pharmaceutical Review

The approval means potentially a further 250,000 patients across the full spectrum of LVEF >40 percent, including HF with reduced, mildly reduced, and preserved ejection fraction (HFrEF, HFmrEF, HFpEF) will be eligible for treatment in England and Wales. percent of patients (n=1361) in the dapagliflozin group and in 45.5

article thumbnail

Leveraging innate cell engagers for lymphoma treatment

European Pharmaceutical Review

Following their introduction, these therapies have moved to early lines of treatment, but unfortunately, a significant number of patients are not cured with these approaches. As a result, when the patient’s lymphoma relapses after treatment with chemotherapy, BV and CPIs, there are no effective treatment alternatives for these patients.

article thumbnail

It’s Time We Got the Most Out of Medical Affairs Data

PM360

Field Medical Affairs is an essential bridge between pharmaceutical clinical development and commercial delivery. Historically, the industry has left MSL-HCP interactions to exist on their own, focusing on objective metrics and key performance indicators (KPIs) to inform Medical Affairs impact.

Medical 52
article thumbnail

What Tech Trends Do Life Sciences Marketers Need to Know About?

PM360

Casey Cronin Life sciences marketers have a unique opportunity to connect with target audiences on an individual level and foster brand safety through AI advancement. AI is also making waves in how to find and target patient communities as healthcare privacy legislation continues to expand in the United States.

article thumbnail

From Europe To The U.S.: A Medtech Executive’s Career Chronicle With Fred Colen

Evolve Your Success

Career success in MedTech is not just about climbing the corporate ladder; it’s about relentlessly advocating for patients, embracing change, and, above all, never giving up. I am a person who has devoted his life to medical technology. We need to bring innovative new therapies to the market and the patients.